Planned website maintenance is taking place from 11:00 pm AEDT on Friday 30 October to 6:00 am AEDT on Saturday 31 October 2026. Some pages may be temporarily unavailable. If issues continue outside this time, please contact us.

AusPAR: Tafluprost/Timolol

Australian Public Assessment Report

AusPAR

AusPAR: Tafluprost/Timolol [PDF, 530.53 KB]

AusPAR: Tafluprost/Timolol [DOCX, 875.11 KB]

Attachment: Product information: Tafluprost/Timolol [PDF, 170.86 KB]

Attachment: Product information: Tafluprost/Timolol [DOCX, 81.07 KB]

Attachment: Extract from the Clinical Evaluation Report: Tafluprost/Timolol [PDF, 2.82 MB]

Attachment: Extract from the Clinical Evaluation Report: Tafluprost/Timolol [DOCX, 6.46 MB]

Device/Product Name

Taptiqom 15/5

Active ingredients

Tafluprost/Timolol

AusPAR Date

28 July 2015

Published

18 August 2015

Submission Number

PM-2013-03652-1-5

Submission Type

New fixed dose combination

Decision

Approved

Product types

Prescription medicines